Side-by-side comparison of AI visibility scores, market position, and capabilities
Adept AI raised $415M to pioneer computer-use AI agents; its core research and agent team moved to Amazon in 2024 in a landmark talent acquisition while the company continues developing ACT-1 for enterprise automation.
Adept AI was founded in 2022 by a team of former OpenAI, DeepMind, and Google Brain researchers to build AI that can take actions on computers — navigating software interfaces, filling forms, and executing multi-step workflows in any application. Its ACT-1 model demonstrated the ability to control web browsers and desktop applications through natural language instructions, pioneering the computer-use agent paradigm that Anthropic later commercialized with Claude's computer use feature.
Science-led synbiotic brand; $56M revenue, profitable, top-5 Amazon probiotic ranking, and expanding into AI-driven microbiome research.
Seed Health is a Los Angeles-based microbial sciences company founded in 2018 by Ara Katz and Raja Dhir. The company is best known for its DS-01 Daily Synbiotic, a two-in-one probiotic and prebiotic capsule developed in partnership with academic researchers. Seed has raised approximately $44 million in total funding, with a Series A led by The Craftory, and has achieved profitability.\n\nThe company reported approximately $56 million in revenue with 500%+ growth over three years, ranking among Amazon's top-five probiotic supplements and selling in Target stores nationwide. Seed differentiates itself by emphasizing clinical research transparency — each strain is backed by published studies, and the brand has become a go-to reference among health-conscious consumers and clinicians.\n\nBeyond consumer products, Seed operates a scientific research arm called SeedLabs that conducts microbiome research in areas including planetary health and pediatric immunity. In 2024, the company announced an AI-powered initiative to accelerate strain discovery. This dual consumer-science identity gives Seed unusual credibility in a supplement category often criticized for weak evidence.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.